Title
Author
DOI
Article Type
Special Issue
Volume
Issue
An apparently benign vulvar mass: possibly a rare malignancy
1Department of Gynaecology, Obstetrics and Reproductive Sciences, Second University of Naples, Naples, Italy
2Department of Medicine and Public Health, Second University of Naples, Naples, Italy
3Department of Dermatology, Livorno Hospital, Livorno , Italy
*Corresponding Author(s): E.M. Messalli E-mail: enricom.messalli@unina2.it
Background: Vulvar dermatofibrosarcoma is a rare fibrous tumor of intermediate grade malignancy, with a tendency for local recurrence, and rarely metastasizes. Management should be multidisciplinary. This is a report of an apparently benign vulvar mass with delayed diagnosis of vulvar dermatofibrosarcoma. Case report: A 42-year-old woman was referred to our hospital because of a vulvar tumor lasting 16 years, although several gynecological procedures and a total laparoscopic hysterectomy had been performed two years before. During this long period the lesion did not change morphological features and remained asymptomatic. Only a benign vulvar mass was diagnosed. Then, the swelling became evident showing erythematous skin with an aspect of "peau d'orange", leading the patient to consult a specialist. A firm vulvar swelling was observed in the anterior third of right labia majora continuing with about 3 cm of cord on top, quite movable above the underlying tissue but not on the overlying tissue. A wide excision was performed. The pathological examination showed positive margins. One month later an extensive deeper excision was performed. Histology confirmed a diagnosis of dermatofibrosarcoma. Immunohistochemistry was strongly positive for CD34. Conclusion: Vulvar lesions always require complete pathologic examination even in case of features of benign tumor to exclude a dermatofibrosarcoma. The role of the pathologist is essential to ensure negative microscopic margins and to avoid local recurrence.
Vulvar neoplasms; Dermatofibrosarcoma; Vulvar mass
E.M. Messalli,M.L. D’Aponte,L. Rossiello,M. Rotondi,P. De Franciscis. An apparently benign vulvar mass: possibly a rare malignancy. European Journal of Gynaecological Oncology. 2012. 33(4);441-444.
[1] Rouhani P., Fletcher C.D., Devesa S.S., Toro J.R.: “Cutaneous soft tissue sarcoma incidence patterns in the U.S.: an analysis of 12,114 cases”. Cancer, 2008, 113, 616.
[2] Zaiden R., Latif N., Pham D., Hosenpud J.: “Dermatofibroma protuberans arising from an insect bite”. Clin. Adv. Hematol. Oncol., 2009, 7, 404.
[3] Ghorbani R.P., Malpica A., Ayala A.G.: “Dermatofibrosarcoma protuberans of the vulva: clinicopathologic and immunohistochemical analysis of four cases, one with fibrosarcomatous change, and review of the literature”. Int. J. Gynecol. Pathol., 1999, 18, 366.
[4] Lindner N.J., Scarborough M.T., Powell G.J., Spanier S., Enneking W.F.: “Revision surgery in dermatofibrosarcoma protuberans of the trunk and extremities”. Eur. J. Surg. Oncol., 1999, 25, 392.
[5] Paradisi A., Abeni D., Rusciani A., Cigna E., Wolter M., Scuderi N. et al.: “Dermatofibrosarcoma protuberans: wide local excision vs mohs micrographic surgery”. Cancer Treat. Rev., 2008, 34, 728.
[6] Gloster H.M. Jr, Harris K.R., Roenigk R.K.: “A comparison between Mohs micrographic surgery and wide surgical excision for the treatment of dermatofibrosarcoma protuberans”. J. Am. Acad. Dermatol., 1996, 35, 82.
[7] Hammonds L.M., Hendi A.: “Dermatofibrosarcoma protuberans of the vulva treated using mohs micrographic surgery”. Dermatol. Surg., 2010, 36, 558.
[8] Sundram U.N.: “Dermatofibrosarcoma protuberans: histologic approach and updated treatment recommendations” (Review). Clin. Adv. Hematol. Oncol., 2009, 7, 406.
[9] Al-Daraji W., Husain E., Zelger B.G., Zelger B.: “A practical andcomprehensive immunohistochemical approach to the diagnosis of superficial soft tissue tumors”. Int. J. Clin. Exp. Pathol., 2009, 2, 119.
[10] Aiba S., Tabata N., Ishii H., Ootani H., Tagami H.: “Dermatofibrosarcoma protuberans is a unique fibrohistiocytic tumour expressing CD34”. Br. J. Dermatol., 1992, 127, 79.
[11] Sachdev R., Sundram U.: “Expression of CD163 in dermatofibroma, cellular fibrous histiocytoma, and dermatofibrosarcoma protuberans: comparison with CD68, CD34, and Factor XIIIa”. J. Cutan Pathol., 2006, 33, 353.
[12] Kutzner H.: “Expression of the human progenitor cell antigen CD34 (HPCA-1) distinguishes dermatofibrosarcoma protuberans from fibrous histiocytoma in formalin-fixed, paraffin-embedded tissue”. J. Am. Acad. Dermatol., 1993, 28, 613.
[13] Goldblum J.R., Reith J.D., Weiss S.W.: “Sarcomas arising in dermatofibrosarcoma protuberans. A reappraisal of biologic behaviour in eighteen cases treated by wide local excision with extended clinical follow-up”. Am. J. Surg. Pathol., 2000, 24, 1125.
Top